SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-012934
Filing Date
2020-05-19
Accepted
2020-05-19 16:17:41
Documents
4
Period of Report
2020-06-30
Effectiveness Date
2020-05-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea122024-def14a_hoththerap.htm DEF 14A 257378
2 GRAPHIC image_001.jpg GRAPHIC 2759
3 GRAPHIC proxy_1.jpg GRAPHIC 386412
4 GRAPHIC proxy_2.jpg GRAPHIC 401069
  Complete submission text file 0001213900-20-012934.txt   1346179
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38803 | Film No.: 20893832
SIC: 2834 Pharmaceutical Preparations